Jean-marc M. Bereder

Nice, FR 
Nice, FR 

Overview

Jean-marc Bereder practices practicing medicine in Nice, France.

Their clinical expertise encompasses Mesothelioma, Colorectal Cancer, Ovarian Cancer, and Stomach Cancer.

They are actively involved in clinical research, co-authoring 25 peer reviewed articles and participating in 2 clinical trials.

Locations

Nice, France
Other Locations
France
CHU Lyon Sud, Hospices Civils de Lyon
Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

GASTRICHIP : D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma. A Randomized and Multicentric Phase III Study.
GASTRICHIP : D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma. A Randomized and Multicentric Phase III Study.
Enrollment Status: Completed
Publish Date: August 24, 2026
Intervention Type: Procedure, Drug
Study Drug: HIPEC with oxaliplatin
Study Phase: Phase 3
A Phase III Randomized Study Evaluating Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in the Treatment of Relapse Ovarian Cancer
A Phase III Randomized Study Evaluating Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in the Treatment of Relapse Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 20, 2026
Intervention Type: Procedure, Drug
Study Drug: Hyperthermic Intra-PEritoneal Chemotherapy
Study Phase: Phase 3
View 1 Less Clinical Trial

25 Total Publications

The clinical benefit of a near complete cytoreduction in patients with colorectal peritoneal metastases: a propensity score matched study.
The clinical benefit of a near complete cytoreduction in patients with colorectal peritoneal metastases: a propensity score matched study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: November 13, 2025

Frequently Asked Questions about Jean-marc M. Bereder

Is Jean-marc M. Bereder a top-rated expert for Mesothelioma?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-marc M. Bereder is classified as an Experienced expert for Mesothelioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-marc M. Bereder participate in research or clinical trials?

Yes. Jean-marc M. Bereder has published 25 articles and abstracts on conditions like Mesothelioma. You can view a list of Jean-marc M. Bereder's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Bereder's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile